메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
안지혜 (Department of Dermatology CHA Bundang Medical Center CHA University School of Medicine Seongnam Kor) 문수진 (Department of Medicine CHA University School of Medicine Pocheon Korea.) 신정우 (Department of Dermatology CHA Bundang Medical Center CHA University School of Medicine Seongnam Kor) 김동현 (Department of Dermatology CHA Bundang Medical Center CHA University School of Medicine Seongnam Kor) 윤문수 (Department of Dermatology CHA Bundang Medical Center CHA University School of Medicine Seongnam Kor) 이희정 (Department of Dermatology CHA Bundang Medical Center CHA University School of Medicine Seongnam Kor)
저널정보
대한피부과학회 Annals of Dermatology Annals of Dermatology 제33권 제6호
발행연도
2021.12
수록면
515 - 521 (7page)
DOI
10.5021/ad.2021.33.6.515

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Background: A rifampicin (RF)-clindamycin (CL) combination therapy is recommended as the first-line treatment for moderate to severe hidradenitis suppurativa (HS). Although the long-term use of RF requires caution due to the possibility of developing resistant bacteria, only a few studies have investigated alternatives for this combination therapy. Objective: To evaluate the efficacy of systemic CL mono-therapy and assess the prevalence and CL resistance of bacterial growth in HS patients. Methods: A total of 53 HS patients treated with CL mono-therapy were included. The efficacy was evaluated by identifying the rate of HS Clinical Response (Hi-SCR) achievers and com- paring HS Physician’s Global Assessment (HS-PGA) before (W0) and after (W8) the treat- ment. Purulent material from HS skin lesions was collected on the W0. Bacterial flora and antibiotic sensitivity were determined by bacterial cultures. Results: Of 53 HS patients, 34 were eligible for evaluation of the efficacy of the therapy. Twen- ty-one patients (61.76%) achieved Hi-SCR. The mean scoring of HS-PGA had significantly decreased from 3.24 to 2.15 ( =0.001). The prevalence of CL resistance was 15.00%. No sig- nificant differences in the efficacy of the therapy according to the presence of CL-resistant bacteria on the W0 were observed ( =0.906). Adverse events occurred in 26.42% of patients. Conclusion: Systemic CL mono-therapy may be a safe and useful alternative to RF-CL com- bination therapy, and no significant difference in the efficacy of the therapy depending on the presence of CL-resistant bacteria was observed.

목차

등록된 정보가 없습니다.

참고문헌 (14)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0